AI Summary
We reviewed 404 live results for skyrizi (risankizumab) sdn bhd and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Immunology.
Comparison Table
Recommended
Skyrizi (risankizumab) Sdn Bhd
Source: AbbVie Malaysia
Description
The Malaysian-market specific supply of Skyrizi, indicated for moderate-to-severe plaque psoriasis and related conditions. It is provided through hospital-based clinical channels and specialized pharmacies.
Best for
Malaysian medical services, psoriasis treatment and rheumatology care
View Details
Rating
Skyrizi (risankizumab) 150mg
Source: AbbVie Singapore
Description
Prescription biologic for the treatment of plaque psoriasis and psoriatic arthritis. The Singapore hub serves as a key regional reference for medical documentation and treatment guidelines for risankizumab therapies in Southeast Asia.
Best for
regional medical reference, Singapore-based patients and biologic therapy information
View Details
Rating
Skyrizi (risankizumab)
Source: AbbVie Pharmaceuticals (Thailand) Ltd.
Description
Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading.
Best for
plaque psoriasis patients, psoriatic arthritis management, Crohn's disease treatment and long-term biologic therapy
View Details
Rating
| Compare | Skyrizi (risankizumab) Sdn Bhd | Skyrizi (risankizumab) 150mg | Skyrizi (risankizumab) |
|---|---|---|---|
| Source | AbbVie Malaysia | AbbVie Singapore | AbbVie Pharmaceuticals (Thailand) Ltd. |
| Description | The Malaysian-market specific supply of Skyrizi, indicated for moderate-to-severe plaque psoriasis and related conditions. It is provided through hospital-based clinical channels and specialized pharmacies. | Prescription biologic for the treatment of plaque psoriasis and psoriatic arthritis. The Singapore hub serves as a key regional reference for medical documentation and treatment guidelines for risankizumab therapies in Southeast Asia. | Skyrizi (risankizumab) is a prescription biological medication used to treat adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease. As an IL-23 inhibitor, it targets the p19 subunit to manage chronic inflammation and is administered via subcutaneous injection, typically requiring a maintenance dose every 12 weeks after initial loading. |
| Best for | Malaysian medical services, psoriasis treatment and rheumatology care | regional medical reference, Singapore-based patients and biologic therapy information | plaque psoriasis patients, psoriatic arthritis management, Crohn's disease treatment and long-term biologic therapy |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Skyrizi (risankizumab) Sdn Bhd from AbbVie Malaysia."
I picked this because Ensures access to the authentic IL-23 inhibitor within Malaysia's pharmaceutical regulatory framework.
Share this search
Related Finds